- Profile
- Personal Information
- Publications
Experts in Clinical Sciences
Natasha Anandaraj Mark White Susan K Birden MICHAEL BILL Pravir Kumar Roger Badia P.Madhava Soma Sundaram Douglas K. Martin Blaine Y. Takesue Karsten Rebner JEFF ANDERSON Syed Umarhathab R.Sivakumar Enanalap Periyar Amy Berkov Kristin Meyer Nora Stelter A.J.R. Albert Heck Simon Allison BIG ANNA MARIA View MoreMr. David Brabazon is a co-founder of Adapt Pharma Limited and serves as Chief Financial Officer and a board member. Adapt Pharma Limited is a US focused speciality pharmaceuticals business with its corporate headquarters in Ireland. Mr. Brabazon previously was a co-founder and Chief Financial Officer of Azur Pharma plc, which merged with Jazz Pharmaceuticals plc in early 2012. Mr. Brabazon continued to serve in the merged business as Senior Vice President of Finance and Company Secretary until late 2012. Prior to Azur Pharma, Mr. Brabazon served as Vice President of Finance and Group Financial Controller of Elan Corporation plc.
Mr. Brabazon is a chartered accountant and holds a Masters of Accounting degree from University College Dublin, Ireland and a Master of Business Administration degree from INSEAD, France. Mr. Brabazon serves as a director of Headway (Ireland) Limited which provides support and services to people affected by brain injury.